Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Liana Gynn"'
Autor:
Liana Gynn
Publikováno v:
British Journal of Haematology. 193:46-76
Publikováno v:
Mutagenesis. 34:e1-e9
Resistance to therapy remains one of the greatest challenges in the management of the blood and bone marrow (BM) disorder, acute myeloid leukaemia (AML). This study aimed to investigate how leukaemic and BM stromal cells contribute to altered chemo-s
Autor:
Jennifer E. May, Gareth M. Robinson, Elizabeth Anderson, Sarah Wexler, Liana Gynn, Christine Cox, Gillian Upstill-Goddard
Publikováno v:
Mutagenesis
Tumour microenvironments are hallmarked in many cancer types. In haematological malignancies, bone marrow (BM) mesenchymal stromal cells (MSC) protect malignant cells from drug-induced cytotoxicity. However, less is known about malignant impact on su
Publikováno v:
Mutagenesis. 33(3)
Mesenchymal stem/stromal cells (MSCs) within the bone marrow (BM) are vitally important in forming the micro-environment supporting haematopoiesis after myeloablative chemotherapy. MSCs are known to be damaged phenotypically and functionally by chemo
Autor:
Jennifer E. May, Sarah Wexler, Christine Cox, Gareth M. Robinson, Liana Gynn, Gillian Upstill-Goddard, Rhys G. Morgan, Elizabeth Anderson
Publikováno v:
Blood. 134:2492-2492
Mesenchymal stromal cells (MSC) are known to protect leukemic cells from drug-induced toxicity within the bone marrow (BM) niche, however, less is known about leukemic impact on supportive MSC. The nucleoside-analogue, cytarabine (Ara-C), is a front-
Autor:
Liana Gynn
Publikováno v:
Liana Gynn
Mesenchymal stromal cells (MSC) enhance growth and protect leukaemic cells from drug-induced toxicity in the bone marrow microenvironment (BMM), however, these interactions are not fully understood and less is known about the impact of leukaemic cell
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::0da8f37798cd4a00943f9471ccc6db93